Therefore, discovering a novel mechanism by which IL‐35‐regulated JAK/STAT signaling pathway in lupus mice model may contribute to the development of new clinical therapeutics for JSLE‐LN disease in future. This evidence concerns the gene SOAT1 and lobular neoplasia.